Kelvin A. Moses
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kelvin A. Moses has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Martha K. Terris
Department of Surgery, Section of Urology, Medical College of Georgia–Augusta University, Augusta, Georgia, USA
5 shared publications- David F. Penson
Department of Urology, Vanderbilt University Medical Center, Nashville, TN
4 shared publications Zachary Klaassen
Department of Surgery, Section of Urology, Medical College of Georgia–Augusta University, Augusta, Georgia, USA
4 shared publicationsLael Reinstatler
Department of Surgery, Section of Urology, Medical College of Georgia–Augusta University, Augusta, Georgia, USA
3 shared publicationsAlicia Brasel
Department of Community Health and Health Behavior, University at Buffalo, Buffalo, NY
2 shared publications- Daniel A. Barocas
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
2 shared publications
Latest Publications
- 1 September 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 198 (3) , 657-662
Development and Initial Testing of the FLOW Instrument: Novel Assessment of Lower Urinary Tract Symptoms in Men
A critical analysis of the AUA symptom score using valid health literacy scales revealed that it is frequently not completed, requires prompting and takes longer to complete for men with low health literacy. The FLOW instrument represents a novel method to assess lower urinary tract symptoms in all men. It represents a valid alternative to the AUA symptom score.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 198 (3) , 657-662
Development and Initial Testing of the FLOW Instrument: Novel Assessment of Lower Urinary Tract Symptoms in Men
A critical analysis of the AUA symptom score using valid health literacy scales revealed that it is frequently not completed, requires prompting and takes longer to complete for men with low health literacy. The FLOW instrument represents a novel method to assess lower urinary tract symptoms in all men. It represents a valid alternative to the AUA symptom score.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 198 (3) , 560-566
The Impact of Health Literacy and Clinicodemographic Factors on Use of Discharge Services after Radical Cystectomy
There are few data on the relationship between health literacy and discharge disposition. We hypothesized that patient discharge needs after radical cystectomy are affected by health literacy. We identified 504 patients who underwent radical cystectomy and completed the validated BHLS (Brief Health Literacy Screen) after November 2010. Bivariate and logistic regression analyses were performed to determine whether health literacy is associated with the use of discharge resources after radical cystectomy. Of patients treated with radical cystectomy 50.6% required discharge services and had lower health literacy (BHLS 11.9 vs 12.5, p = 0.016) than patients discharged home without services. On multivariable analysis older age (OR 1.1, 95% CI 1.0-1.1, p = 0.002), female gender (OR 2.3, 95% CI 1.2-4.4, p = 0.019), body mass index (OR 1.1, 95% CI 1.0-1.1, p = 0.034), Charlson comorbidity index score (OR 1.1, 95% CI 1.0-1.2, p = 0.037) and length of stay (OR 1.1, 95% CI 1.0-1.2, p = 0.019) were significantly associated with the use of discharge resources. Patients with continent vs incontinent urinary diversion were less likely to require discharge services (OR 0.4, 95% CI 0.2-0.8, p = 0.013). Older age, female gender, body mass index, comorbidities, length of stay and incontinent diversion are associated with increased use of discharge resources after radical cystectomy. Low health literacy may affect patient discharge disposition but it was not significant on multivariable analysis. Factors that influence the complex self-care required of patients after cystectomy should be considered during discharge planning.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 198 (3) , 560-566
The Impact of Health Literacy and Clinicodemographic Factors on Use of Discharge Services after Radical Cystectomy
There are few data on the relationship between health literacy and discharge disposition. We hypothesized that patient discharge needs after radical cystectomy are affected by health literacy. We identified 504 patients who underwent radical cystectomy and completed the validated BHLS (Brief Health Literacy Screen) after November 2010. Bivariate and logistic regression analyses were performed to determine whether health literacy is associated with the use of discharge resources after radical cystectomy. Of patients treated with radical cystectomy 50.6% required discharge services and had lower health literacy (BHLS 11.9 vs 12.5, p = 0.016) than patients discharged home without services. On multivariable analysis older age (OR 1.1, 95% CI 1.0-1.1, p = 0.002), female gender (OR 2.3, 95% CI 1.2-4.4, p = 0.019), body mass index (OR 1.1, 95% CI 1.0-1.1, p = 0.034), Charlson comorbidity index score (OR 1.1, 95% CI 1.0-1.2, p = 0.037) and length of stay (OR 1.1, 95% CI 1.0-1.2, p = 0.019) were significantly associated with the use of discharge resources. Patients with continent vs incontinent urinary diversion were less likely to require discharge services (OR 0.4, 95% CI 0.2-0.8, p = 0.013). Older age, female gender, body mass index, comorbidities, length of stay and incontinent diversion are associated with increased use of discharge resources after radical cystectomy. Low health literacy may affect patient discharge disposition but it was not significant on multivariable analysis. Factors that influence the complex self-care required of patients after cystectomy should be considered during discharge planning.
- 11 July 2017
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 20 (4) , 424-429
The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study
Variation in PSA screening is a potential source of disparity in prostate cancer survival, particularly among underserved populations. We sought to examine the impact of race and socioeconomic status (SES) on receipt of PSA testing among low-income men. Black (n=22 167) and White (n=9588) men aged 40 years completed a baseline questionnaire from 2002 to 2009 as part of the Southern Community Cohort Study. Men reported whether they had ever received PSA testing and had testing within the prior 12 months. To evaluate the associations between SES, race and receipt of PSA testing, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from the multivariable logistic models where age, household income, insurance status, marital status, body mass index and educational level were adjusted. Black men were younger, had a lower income, less attained education and were more likely to be unmarried and uninsured (all P<0.001). Percentages of men having ever received PSA testing rose from 50 more likely than Blacks to have received testing. Lower SES was significantly associated with less receipt of PSA testing in both groups. After adjustment for SES, White men had significantly lower odds of PSA testing (OR 0.81; 95% CI: 0.76–0.87). Greater PSA testing among White than Black men over the age of 50 years in this low-income population appears to be mainly a consequence of SES. Strategies for PSA screening may benefit from tailoring to the social circumstances of the men being screened.
- 11 July 2017
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 20 (4) , 424-429
The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study
Variation in PSA screening is a potential source of disparity in prostate cancer survival, particularly among underserved populations. We sought to examine the impact of race and socioeconomic status (SES) on receipt of PSA testing among low-income men. Black (n=22 167) and White (n=9588) men aged 40 years completed a baseline questionnaire from 2002 to 2009 as part of the Southern Community Cohort Study. Men reported whether they had ever received PSA testing and had testing within the prior 12 months. To evaluate the associations between SES, race and receipt of PSA testing, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from the multivariable logistic models where age, household income, insurance status, marital status, body mass index and educational level were adjusted. Black men were younger, had a lower income, less attained education and were more likely to be unmarried and uninsured (all P<0.001). Percentages of men having ever received PSA testing rose from 50 more likely than Blacks to have received testing. Lower SES was significantly associated with less receipt of PSA testing in both groups. After adjustment for SES, White men had significantly lower odds of PSA testing (OR 0.81; 95% CI: 0.76–0.87). Greater PSA testing among White than Black men over the age of 50 years in this low-income population appears to be mainly a consequence of SES. Strategies for PSA screening may benefit from tailoring to the social circumstances of the men being screened.
- 20 February 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (6_suppl) , 218
Patient expectations from systemic treatment of metastatic prostate cancer (mPC).
218 Background: Multiple systemic therapies prolong the survival of men with mPC, but the disease remains incurable. High-quality treatment decisions require an informed understanding of the purpose of treatment and expected risks and benefits, particularly because cancer patients may accept otherwise unacceptable treatment if they believe there is a ≥ 1% chance of cure. Reconciling patient expectations with expected outcomes of providers is necessary to prevent treatment with toxic therapies that patients would refuse if cure were not possible. We assessed patient expectations from treatment among men receiving systemic therapy for mPC. Methods: Between 6/1/15 and 9/29/16, men with mPC completed surveys defining expectations of cure from their current mPC treatment. We used frequencies and relative frequencies to describe expectations, and proportional odds models with robust standard errors to assess the association between expectations, optimism, clinical characteristics, and sociodemographic factors. Results: Among 96 men completing surveys, 32 (33%) reported that cure was at least a little likely (8% very likely, 14% somewhat likely, and 11% a little likely). Higher optimism scores were associated with higher expectations of cure (adjusted OR 2.5, 95% CI 1.3-4.8 for most versus least optimistic), and non-white race was associated with lower expectations of cure as compared with white patients (adjusted OR 0.08, 95% CI 0.02 – 0.3). Report of excellent or good overall health was associated with greater odds of expecting cure than report of fair or poor health (adjusted OR 13, 95% CI 1.3 – 125). Marital status and age were not associated with expectations. Conclusions: Up to 1/3 of men with mPC receive treatment with an expectation that it may cure their cancer. Men with greater optimism and better reported health status have greater odds of expecting cure. Actions to align patient and physician expectations are necessary to adequately counsel patients and avoid overtreatment with toxic therapies.
- 20 February 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (6_suppl) , 218
Patient expectations from systemic treatment of metastatic prostate cancer (mPC).
218 Background: Multiple systemic therapies prolong the survival of men with mPC, but the disease remains incurable. High-quality treatment decisions require an informed understanding of the purpose of treatment and expected risks and benefits, particularly because cancer patients may accept otherwise unacceptable treatment if they believe there is a ≥ 1% chance of cure. Reconciling patient expectations with expected outcomes of providers is necessary to prevent treatment with toxic therapies that patients would refuse if cure were not possible. We assessed patient expectations from treatment among men receiving systemic therapy for mPC. Methods: Between 6/1/15 and 9/29/16, men with mPC completed surveys defining expectations of cure from their current mPC treatment. We used frequencies and relative frequencies to describe expectations, and proportional odds models with robust standard errors to assess the association between expectations, optimism, clinical characteristics, and sociodemographic factors. Results: Among 96 men completing surveys, 32 (33%) reported that cure was at least a little likely (8% very likely, 14% somewhat likely, and 11% a little likely). Higher optimism scores were associated with higher expectations of cure (adjusted OR 2.5, 95% CI 1.3-4.8 for most versus least optimistic), and non-white race was associated with lower expectations of cure as compared with white patients (adjusted OR 0.08, 95% CI 0.02 – 0.3). Report of excellent or good overall health was associated with greater odds of expecting cure than report of fair or poor health (adjusted OR 13, 95% CI 1.3 – 125). Marital status and age were not associated with expectations. Conclusions: Up to 1/3 of men with mPC receive treatment with an expectation that it may cure their cancer. Men with greater optimism and better reported health status have greater odds of expecting cure. Actions to align patient and physician expectations are necessary to adequately counsel patients and avoid overtreatment with toxic therapies.
- 20 February 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (6_suppl) , 207
The association of BMI and PSA density on survival among patients with metastatic or castration-resistant prostate cancer.
207 Background: The majority of deaths from prostate cancer are among men with metastatic (mPCa) or castration-resistant prostate cancer (CRPC). Long-term outcomes of these patients are generally not well characterized as data from most randomized trials were censored at interim analysis. The objective of our study is to investigate factors associated with survival in a dedicated outpatient clinic. Variables of interest included body mass index (BMI) and PSA density (PSAD) at diagnosis, as well as initial treatment. Methods: All patients with mPCa or CRPC seen in the Vanderbilt Comprehensive Prostate Cancer Clinic were eligible. Demographic and pathologic information were extracted from the electronic record under IRB-protocol. Overall survival (OS) was estimated using the Kaplan-Meier method. Multivariate analyses using Cox proportional hazard models were also performed. Results: Clinicopathological data was available for 65 patients at interim analysis of a total of 198 patients. Median follow-up was 7.4 years and median BMI was 28.5 kg/m2. Disease characteristics included 31/65 (47.5%) with Gleason 8 or greater on biopsy, median PSAD of 0.34, and 14 (23.3%) presenting with M1 disease. Patients underwent surgery (53%), radiation (20%) or androgen deprivation (ADT, 24.6%) initial therapy. BMI > 30 kg/m2 was associated with lower 5-year mortality (6.5% vs. 13.3% BMI < 30 kg/m2, p = 0.042). In addition, PSAD above median was associated with worse 5-year mortality (37.7% vs 6.1% PSAD < 0.34, p = 0.048). Initial treatment was also associated with 5-year mortality (10% surgery vs 0% radiation vs 100% ADT, p < 0.01). Multivariate analysis showed BMI is independently associated with OS (HR 0.807 (95% CI 0.70-0.93), p < 0.01) correcting for age and stage. Conclusions: We show BMI, PSAD and initial treatment are associated with survival for patients who develop advanced prostate cancer. Furthermore, BMI is significantly associated with survival in this cohort. The survival benefit of surgery likely reflects the higher percentage of M1 disease among patients who receive ADT only. Our findings should prompt further analysis of the impact of clincopathlogic factors and treatment type in a larger cohort.
- 20 February 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (6_suppl) , 207
The association of BMI and PSA density on survival among patients with metastatic or castration-resistant prostate cancer.
207 Background: The majority of deaths from prostate cancer are among men with metastatic (mPCa) or castration-resistant prostate cancer (CRPC). Long-term outcomes of these patients are generally not well characterized as data from most randomized trials were censored at interim analysis. The objective of our study is to investigate factors associated with survival in a dedicated outpatient clinic. Variables of interest included body mass index (BMI) and PSA density (PSAD) at diagnosis, as well as initial treatment. Methods: All patients with mPCa or CRPC seen in the Vanderbilt Comprehensive Prostate Cancer Clinic were eligible. Demographic and pathologic information were extracted from the electronic record under IRB-protocol. Overall survival (OS) was estimated using the Kaplan-Meier method. Multivariate analyses using Cox proportional hazard models were also performed. Results: Clinicopathological data was available for 65 patients at interim analysis of a total of 198 patients. Median follow-up was 7.4 years and median BMI was 28.5 kg/m2. Disease characteristics included 31/65 (47.5%) with Gleason 8 or greater on biopsy, median PSAD of 0.34, and 14 (23.3%) presenting with M1 disease. Patients underwent surgery (53%), radiation (20%) or androgen deprivation (ADT, 24.6%) initial therapy. BMI > 30 kg/m2 was associated with lower 5-year mortality (6.5% vs. 13.3% BMI < 30 kg/m2, p = 0.042). In addition, PSAD above median was associated with worse 5-year mortality (37.7% vs 6.1% PSAD < 0.34, p = 0.048). Initial treatment was also associated with 5-year mortality (10% surgery vs 0% radiation vs 100% ADT, p < 0.01). Multivariate analysis showed BMI is independently associated with OS (HR 0.807 (95% CI 0.70-0.93), p < 0.01) correcting for age and stage. Conclusions: We show BMI, PSAD and initial treatment are associated with survival for patients who develop advanced prostate cancer. Furthermore, BMI is significantly associated with survival in this cohort. The survival benefit of surgery likely reflects the higher percentage of M1 disease among patients who receive ADT only. Our findings should prompt further analysis of the impact of clincopathlogic factors and treatment type in a larger cohort.
- Open Access
- 23 November 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0166594
The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy
Epidemiological data suggest that omega-6 (ω-6) fatty acids (FAs) may be associated with cancer incidence and/or cancer mortality, whereas ω-3 FAs are potentially protective. We examined the association of the ratio of ω-6 to ω-3 FA (ω-6:ω-3) and individual FA components with pathological results among men with prostate cancer (PCa) undergoing radical prostatectomy. Sixty-nine men were included in the study. Components of ω-6 (linoleic acid (LA), arachidonic acid (AA), and dihomo-γ-linolenic acid (DGLA)) and ω-3 (docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)) were analyzed by liquid chromatography/mass selective detector separation. Logistic regression analysis was performed to determine association of FA with pathological high grade (Gleason ≥4+3) disease. The were 35 men with low grade disease (Gleason ≤3+4) and 34 men with high grade disease. Men with low grade disease were significantly younger (58y vs 61y, p = 0.012) and had lower D’Amico clinical classification (p = 0.001) compared to men with high grade disease. There was no significant association of ω-6:ω-3 with high grade disease (OR 0.93, p = 0.78), however overall ω-6, ω-3, and individual components of ω-6 and ω-3 FAs except EPA were significantly associated with high grade disease (ω-6: OR 3.37, 95% CI: 1.27,8.98; LA: OR 3.33, 95% CI:1.24,8.94; AA: OR 2.93, 95% CI:1.24,6.94; DGLA: OR 3.21, 95% CI:1.28,8.04; ω-3: OR 3.47, 95% CI:1.22,9.83; DHA: OR 3.13, 95% CI:1.26,7.74). ω-6 and ω-3 FA components were highly correlated (Spearman ρ = 0.77). Higher levels of individual components of ω-6 and ω-3FAs may be associated with higher-grade PCa. Studies into the causative factors/pathways regarding FAs and prostate carcinogenesis may prove a potential association with PCa aggressiveness.
- 23 November 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0166594
Open AccessThe Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy
Epidemiological data suggest that omega-6 (ω-6) fatty acids (FAs) may be associated with cancer incidence and/or cancer mortality, whereas ω-3 FAs are potentially protective. We examined the association of the ratio of ω-6 to ω-3 FA (ω-6:ω-3) and individual FA components with pathological results among men with prostate cancer (PCa) undergoing radical prostatectomy. Sixty-nine men were included in the study. Components of ω-6 (linoleic acid (LA), arachidonic acid (AA), and dihomo-γ-linolenic acid (DGLA)) and ω-3 (docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)) were analyzed by liquid chromatography/mass selective detector separation. Logistic regression analysis was performed to determine association of FA with pathological high grade (Gleason ≥4+3) disease. The were 35 men with low grade disease (Gleason ≤3+4) and 34 men with high grade disease. Men with low grade disease were significantly younger (58y vs 61y, p = 0.012) and had lower D’Amico clinical classification (p = 0.001) compared to men with high grade disease. There was no significant association of ω-6:ω-3 with high grade disease (OR 0.93, p = 0.78), however overall ω-6, ω-3, and individual components of ω-6 and ω-3 FAs except EPA were significantly associated with high grade disease (ω-6: OR 3.37, 95% CI: 1.27,8.98; LA: OR 3.33, 95% CI:1.24,8.94; AA: OR 2.93, 95% CI:1.24,6.94; DGLA: OR 3.21, 95% CI:1.28,8.04; ω-3: OR 3.47, 95% CI:1.22,9.83; DHA: OR 3.13, 95% CI:1.26,7.74). ω-6 and ω-3 FA components were highly correlated (Spearman ρ = 0.77). Higher levels of individual components of ω-6 and ω-3FAs may be associated with higher-grade PCa. Studies into the causative factors/pathways regarding FAs and prostate carcinogenesis may prove a potential association with PCa aggressiveness.
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 196 (4) , 1030-1035
Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women
We investigated oncologic and urinary outcomes after anterior exenteration for urothelial cell carcinoma in females, identifying tumor characteristics associated with female pelvic organ involvement. We hypothesized that a lack of trigonal or bladder floor tumor, intraoperative palpable posterior mass and clinical lymphadenopathy is associated with a lack of female pelvic organ involvement. We retrospectively reviewed the charts of female patients who underwent radical cystectomy at our institution from 1999 to 2014. Patient and operative characteristics were extracted from the electronic medical record, and performance of hysterectomy was tested for association with disease recurrence. Categorical and continuous variables were analyzed with the chi-square and Student t-test, and Kaplan-Meier analysis was performed to determine recurrence-free survival according to hysterectomy performance. Women who had neobladder creation were additionally evaluated for an association between hysterectomy status, and nighttime wetting and catheter use. Of 322 eligible patients 160 with urothelial cancer did not have a hysterectomy before cystectomy. Mean followup was 2.2 years (SD 2.8). There were 22 patients (13.8%) who had recurrence during followup. No patient or surgical factor other than use of adjuvant chemotherapy or radiation (p <0.01) was associated with recurrence. Of 139 women 32 (23.0%) who underwent exenteration had female pelvic organ involvement. At least 1 of the 3 characteristics of interest were present in 28 of 99 (28.3%) women with any genitourinary organ involvement compared to only 4 of 40 (10.0%) of those who did not (p=0.01). Nighttime continence ranged between 21.9% and 48% but there was no significant association with continence and hysterectomy status. Lack of trigonal/bladder floor tumor, palpable posterior mass and clinical lymphadenopathy is associated with the absence of pelvic organ involvement. Individualized risk assessment using these factors along with patient preferences should be used to guide surgical planning.
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 196 (4) , 1030-1035
Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women
We investigated oncologic and urinary outcomes after anterior exenteration for urothelial cell carcinoma in females, identifying tumor characteristics associated with female pelvic organ involvement. We hypothesized that a lack of trigonal or bladder floor tumor, intraoperative palpable posterior mass and clinical lymphadenopathy is associated with a lack of female pelvic organ involvement. We retrospectively reviewed the charts of female patients who underwent radical cystectomy at our institution from 1999 to 2014. Patient and operative characteristics were extracted from the electronic medical record, and performance of hysterectomy was tested for association with disease recurrence. Categorical and continuous variables were analyzed with the chi-square and Student t-test, and Kaplan-Meier analysis was performed to determine recurrence-free survival according to hysterectomy performance. Women who had neobladder creation were additionally evaluated for an association between hysterectomy status, and nighttime wetting and catheter use. Of 322 eligible patients 160 with urothelial cancer did not have a hysterectomy before cystectomy. Mean followup was 2.2 years (SD 2.8). There were 22 patients (13.8%) who had recurrence during followup. No patient or surgical factor other than use of adjuvant chemotherapy or radiation (p <0.01) was associated with recurrence. Of 139 women 32 (23.0%) who underwent exenteration had female pelvic organ involvement. At least 1 of the 3 characteristics of interest were present in 28 of 99 (28.3%) women with any genitourinary organ involvement compared to only 4 of 40 (10.0%) of those who did not (p=0.01). Nighttime continence ranged between 21.9% and 48% but there was no significant association with continence and hysterectomy status. Lack of trigonal/bladder floor tumor, palpable posterior mass and clinical lymphadenopathy is associated with the absence of pelvic organ involvement. Individualized risk assessment using these factors along with patient preferences should be used to guide surgical planning.
- 1 September 2016
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34 (9) , 415.e7-415.e12
Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer
- 1 September 2016
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34 (9) , 415.e7-415.e12
Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer
- 22 August 2016
- Published by Taylor & Francis in Journal of Health Communication
- Vol. 21 (sup2) , 99-104
The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy
Health literacy is the ability to obtain, comprehend, and act on medical information and is an independent predictor of health outcomes in patients with chronic health conditions. However, little has been reported regarding the potential association of health literacy and surgical outcomes. We hypothesized that patient complications after radical cystectomy would be associated with health literacy. In a sample of 368 patients, we found that higher health literacy scores (as determined by the Brief Health Literacy Screen) were associated with decreased odds of developing minor complications (odds ratio = 0.90, 95% confidence interval [0.83, 0.97]). Health literacy should be considered when caring for patients undergoing radical cystectomy and should serve as a potential indicator of the need for additional resources to improve postoperative outcomes.
- 22 August 2016
- Published by Taylor & Francis in Journal of Health Communication
- Vol. 21 (sup2) , 99-104
The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy
Health literacy is the ability to obtain, comprehend, and act on medical information and is an independent predictor of health outcomes in patients with chronic health conditions. However, little has been reported regarding the potential association of health literacy and surgical outcomes. We hypothesized that patient complications after radical cystectomy would be associated with health literacy. In a sample of 368 patients, we found that higher health literacy scores (as determined by the Brief Health Literacy Screen) were associated with decreased odds of developing minor complications (odds ratio = 0.90, 95% confidence interval [0.83, 0.97]). Health literacy should be considered when caring for patients undergoing radical cystectomy and should serve as a potential indicator of the need for additional resources to improve postoperative outcomes.